Abstract: ZFAT was originally identified as an immune-related transcriptional regulator containing 18 C2H2-type zinc-finger domains and one AT-hook. ZFAT is highly conserved among species and functions as an anti-apoptotic molecule in the lymphoblastic leukemia cell line, MOLT-4. We recently demonstrated that ZFAT is an essential molecule for hematopoietic differentiation in blood islands through the direct regulation of particular transcriptional factors, including Tal1, for endothelial cell assembly, and for the branch point formation of capillary-like structures. However, the molecular mechanisms underlying the anti-apoptotic function of ZFAT remain unknown. Here, we report that ZFAT knockdown by small interfering RNA induced apoptosis in mouse embryonic fibroblasts (MEFs). This response had been similarly observed for MOLT-4 cells. To explore the molecular mechanisms for ZFAT in anti-apoptotic function in both MEFs and MOLT-4 cells, microarray expression analysis and quantitative RT-PCR were done. Of interest was that Bcl-2 and Il6st were identified as commonly down-regulated genes by the depletion of ZFAT for both MEFs and MOLT-4 cells. These results suggest that ZFAT is a critical molecule for cell survival in MEFs and MOLT-4 cells at least in part through the regulation of the apoptosis involved in the BCL-2-and IL6st- 
INTRODUCTION
Autoimmune thyroid disease (AITD), including Graves' disease and Hashimoto thyroiditis, is caused by an immune response to self-thyroid antigens. It affects 2-5% of the general population [1] . Through linkage and association analyses on a large group of Japanese AITD patients [2, 3] , we identified ZFAT (the zincfinger gene in the AITD susceptibility region) as a susceptibility gene for AITD [3] . The human ZFAT gene encodes a 1,243-amino acid residue protein containing one AT-hook and 18 C2H2 zinc-finger domains. ZFAT is also highly conserved among species from fish to human [4] . The ZFAT protein is expressed in the B and T lymphocytes in mice, and ZFAT regulates the genes involved in immune responses [4] . Furthermore, we previously demonstrated that ZFAT is an anti-apoptotic molecule that is critical for cell survival in human leukemic MOLT-4 cells [5] . Recently, we demonstrated that Zfat-deficiency (Zfat -/-) is lethal for mice by embryonic day (E) 8.5, with a reduction in the number of blood islands and hematopoietic progenitor cells. ZFAT directly regulates the transcription factors including Tal1, Lmo2 and Gata1 in the blood islands [6] . We also reported that ZFAT is essential for endothelial cell assembly and the branch point formation of capillary-like structures in an angiogenesis model, suggesting that ZFAT is a critical transcriptional regulator for endothelial differentiation [7] . Genetic variants of ZFAT were reported to be associated with adult height in the Japanese and Korean populations [8] , and with interferon-beta responsiveness in multiple sclerosis in western populations [9] . These reports and our previous findings together suggest the possibility that ZFAT is as a critical regulator not only in immune responses but also in growth, differentiation and apoptosis for the mesoderm-derived and mesenchymal cells. In this study, to characterize the biological functions for ZFAT in mouse embryonic fibroblasts (MEFs), we investigated the effects of ZFAT depletion through the use of siRNA targeting ZFAT in MEFs, showing that the depletion of ZFAT by siRNA knockdown significantly induced apoptosis in MEFs. Furthermore, we identified the Bcl-2 and Il6st genes as the genes commonly regulated by ZFAT for both MEFs and MOLT-4 cells.
MATERIALS AND METHODS
Preparation of the mouse embryonic fibroblasts, and cell culture Primary MEFs were isolated from E13-14 embryos of C57BL/6 mice and cultured at 37ºC in Dulbecco's modified Eagle's medium (DMEM) with 10% heat-inactivated fetal bovine serum, 0.1 mmol/l non-essential amino acids, 50 μmol/l 2-mercaptoethanol and antibiotics. The experiments on the mice were approved by the University Committee on Animal Resources in the animal facility of Fukuoka University.
siRNAs and transfection
The siRNA for ZFAT and scrambled control siRNA were obtained from Invitrogen (Stealth RNAi). The sequences of the ZFAT stealth siRNAs were:
mZFAT-siRNA (for MEFs, mouse) 5'-AUC UGC UGC AGG AUA UUC ACA GCG G-3' and 5'-CCG CUG UGA AUA UCC UGC AGC AGA U-3'; control-siRNA 5'-AUC GAU GUC GGG ACU AUA CAC UCG G-3' and 5'-CCG AGU GUA UAG UCC CGA CAU CGA U-3'; hZFAT-siRNA (for MOLT-4, human) 5'-AAC AUU UAC ACA UAA AGA UGG CCG U-3' and 5'-ACG GCC AUC UUU AUG UGU AAA UGU U-3'; control-siRNA 5'-AAC CGA UUA UAC ACA UAA AGG UCG U-3' and 5'-ACG ACC UUU AUG UGU AUA AUC GGU U-3'. For each experiment, early passages (2 to 4) MEFs were plated at a density of 5 x 10 5 cells per 6-cm dish. The MEFs were transfected with either mZFATsiRNA or control-siRNA using the Lipofectamine RNAi MAX reagent (Invitrogen) following the manufacturer's suggested protocol. The MOLT-4 cells were transfected with either hZFAT-siRNA or control-siRNA, as described previously [5] .
Western blot analysis
Cells were lysed with a buffer containing 1% Nonidet P40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and a protease inhibitor cocktail (Roche). The total cell lysates were subjected to SDS-PAGE and transferred to Nitrocellulose Transfer Membrane (Whatman). Western blot was done as described previously [6] using anti-ZFAT monoclonal antbody [6] or anti-ERK1 antibody (K-23; Santa Cruz Biotechnology). The signals were detected via enhanced chemiluminescence following the manufacturer's instructions (ECL detection system, Amersham).
Proliferation analysis
The proliferation activity was measured with the tetrazolium compound WST-8 (Cell Counting Kit-8; Dojindo Laboratories). The cells were plated in 48-well tissue culture plates at a density of 1 × 10 4 cells per well in 200 μl of medium, and were transfected with siRNA. After 24, 48 and 72 h, 10 μl of WST-8 solution was added to each well, followed by incubation at 37ºC for 30 min. Absorbance at 450 nm was measured using a microplate reader.
Apoptosis assay
Cells were plated in 48-well tissue culture plates at a density of 1 × 10 4 cells per well in 200 μl of medium and were transfected with siRNA. Caspase-3 and -7 activities were determined at 24 and 48 h using the Caspase-Glo 3/7 assay (Promega) by measuring luminescence as relative light units (RLUs) using a GLOMAX luminometer (Promega).
Expression array analyses and quantitative RT-PCR
Total RNA was extracted from the siRNA-transfected cells using a Qiagen RNeasy kit. The preparation of the biotinylated antisense cRNA, the hybridization to the GeneChip Human Genome U133 Plus 2.0 array (for MOLT-4 cells) or to the GeneChip Mouse Genome 430 2.0 array (for MEFs) (Affymetrix), and the washing, scanning and data processing were performed according to the manufacturers' instructions and as described previously [4] . Output files were then loaded into GeneSpring v11.0 (Agilent Technologies) with per gene normalization to the expression level of the control siRNAtransfected cells. Quantitative RT-PCR was performed using ABI PRISM 7900HT (Applied Biosystems) and Perfect Real Time Support System (TAKARA) [6] . The PCR primer IDs used for each of the 22 genes are listed in Supplementary Tab. 1 at http://dx.doi.org/10.2478/s11658-010-0041-1. Relative quantification for each gene expression was normalized by the expression level of β-actin or Gapdh. The data is presented as the means ± standard deviations of the means of triplicate samples.
Statistical analysis
The data is presented as the means ± standard deviations of the means of triplicate samples. Statistical analyses were performed with an unpaired Student's t-test. Differences at P < 0.05 are considered to be statistically significant.
RESULTS AND DISCUSSION

Apoptosis is induced by the depletion of ZFAT in MEFs
To characterize the biological functions for ZFAT in C57BL/6 MEFs, MEFs were transfected with mZFAT-siRNA or control-siRNA. ZFAT protein expression in MEFs transfected with mZFAT-siRNA was evidently suppressed compared with that in MEFs transfected with control-siRNA (Fig. 1A) . As shown in Fig. 1B , depletion of ZFAT by siRNA knockdown significantly induced the reduction in cell proliferation at 48 and 72 h. To determine whether or not apoptosis is involved in the inhibition of cell growth, the activation of caspase-3 and -7 was analyzed. The activities of caspase-3 and -7 in MEFs transfected with ZFAT-siRNA were increased 1.74-fold at 24 h and 1.89-fold at 48 h, compared with those in MEFs transfected with control-siRNA (Fig. 1C) , indicating that apoptosis was induced by ZFAT siRNA knockdown and that ZFAT is essential for cell survival for MEFs.
Genes regulated by ZFAT in the functions of apoptosis, cell growth and immune responses
To identify the genes commonly regulated by ZFAT in both MEFs and MOLT-4 cells, we compared the gene expression profiles of MEFs transfected with mZFAT-siRNA or control-siRNA and MOLT-4 cells transfected with hZFATsiRNA or control-siRNA using microarray expression analysis. A gene was considered to be differentially expressed in ZFAT knockdown cells when the Fig. 1 . The depletion of ZFAT by siRNA knockdown induces apoptosis in MEFs. Cells were transfected with mZFAT-siRNA or control-siRNA. A -The effects of siRNA on the levels of ZFAT protein expression. Western blot analysis for ZFAT expression at 24 h after transfection in MEFs transfected with mZFAT-siRNA or control-siRNA. ERK1 was used as a loading control. B -Suppression of cell growth in MEFs due to ZFAT knockdown. The cells were transfected with siRNA, and cell growth was determined at the indicated time points after transfection using the WST-8 colorimetric assay. The data is the average of three replicates ± S.D. C -Caspase-3 and -7 activity in MEFs with ZFAT knockdown. MEFs transfected with mZFAT-siRNA or control-siRNA were plated at 1 × 10 4 cells per well in 48-well plates. After 24 and 48 h, the caspase-3 and -7 activity was quantified. The activity was measured by cleavage of the fluorescent caspase-3 and -7 substrate Ac-DEVD-pNA. The data is the average of three replicates ± S.D. Statistically significant differences are indicated as *P < 0.01.
fold change was greater than or less than 1.25, compared with that of the cells transfected with control-siRNA. Based on these criteria, 131 genes were selected as the genes commonly down-regulated by depletion of ZFAT both in MEFs and in MOLT-4 cells. From the point of view of ZFAT functions in MEFs, the differentially expressed genes involved in cell death were Bcl-2, Gfra1, Nek1 and Perp; in cellular growth and proliferation, they were Adam17, Akap13, Cadm1, Depdc6, Jag1, Mxd1, Mid1, Nf2, Pmp22, Prrx1, Tmeff2, Vegfa and Zfhx3; and in immune responses, they were Bcl-6, Cxcl3, Flt1 and Il6st (Tabs 1 and 2). To confirm the microarray gene expression data, the 21 detected differentially expressed genes were analyzed via quantitative RT-PCR. There was a concordant relationship between the data obtained from microarray expression analysis and quantitative RT-PCR (Supplementary Tab. 2). Quantitative RT-PCR analysis showed that the mRNA levels of six of the genes (Bcl-2, Depdc6, Flt1, Il6st, Gfra1 and Pmp22) in the ZFAT-siRNA-transfected MEFs and MOLT-4 cells were significantly reduced compared with those in the control-siRNAtransfected MEFs and MOLT-4 cells (fold change compared with each control: Bcl-2, -2.3 (MEFs), -2.5 (MOLT-4); Depdc6, -2.2, -1.7; Flt1, -1.3, -1.4; Il6st, -1.4, -1.7; Gfra1, -2.0, -1.5; Pmp22, -3.0, -1.6, respectively; Fig. 2 ). Of note is that the Bcl-2 mRNA levels in the ZFAT-siRNA-transfected MEFs and MOLT-4 cells were reduced to more than 50% of those in MEFs transfected with controlsiRNA, suggesting that the reduction in BCL-2 expression may lead to an increase in caspase-3 activity, culminating in apoptosis in MEFs and MOLT-4 cells. The data is the average of three replicates ± S.D. Statistically significant differences are indicated as *P < 0.05, **P < 0.01.
In this article, we demonstrated that ZFAT knockdown by small interfering RNA in MEFs also induced apoptosis as with MOLT-4 cells [5] . Furthermore, we showed that particular apoptosis-related genes including Bcl-2 and Il6st were down-regulated by the depletion of ZFAT both in MEFs and in MOLT-4 cells. Together, this suggests that ZFAT critically regulates the expressions of Bcl-2 and Il6st (Fig. 3) . ZFAT is highly conserved among ZFAT orthologues from fish to mammalian species [4] , and Zfat -/-mice die by embryonic day (E) 8.5 [6] , indicating that ZFAT plays pivotal roles in mouse development. ZFAT knockdown by small interfering RNA in MEFs induced apoptosis, supporting the hypothesis that ZFAT is essential for cell survival and plays a critical role in mesoderm-derived cells and mesenchymal cells. BCL-2 is a negative regulator for cellular apoptosis and a major regulator of the intrinsic apoptosis pathways [10] . Our data indicated that the reduced BCL-2 expression might result in an increase in caspase-3 activity in MEFs and MOLT-4 cells transfected with ZFAT-siRNA. On the other hand, Il6st (also known as gp130) is a common subunit for the interleukin-6 (IL-6) family of cytokines, which are involved in cell proliferation, differentiation and cell death in various tissues [11] . The mutation of tyrosine 767 in the membrane-proximal 133 amino acid residues of IL6st disrupts STAT3 activation, resulting in apoptosis and the loss of Bcl-2 induction [12] . Depletion of ZFAT in MEFs and MOLT-4 cells induced a reduction in the expressions of Il6st and Bcl-2, suggesting that IL6st and BCL-2 participate in the ZFAT-mediated anti-apoptosis function. Depdc6 encodes DEPTOR, which is a novel binding partner for mTOR [13, 14] . Depleting multiple myeloma cells of DEPTOR activates mTORC1 and inhibits PKB phosphorylation, and inhibits proliferation and induces apoptosis [13] . Our data demonstrated that Depdc6 mRNA was down-regulated by the depletion of ZFAT. The molecular mechanisms underlying the apoptosis induced by the depletion of ZFAT in MEFs and MOLT-4 cells might be involved in DEPTORand mTOR-mediated signaling pathways (Fig. 3) . Flt1 (also known as VEGFR1) plays an active role in vascular endothelial growth factor-mediated (VEGF-mediated) autocrine signaling of tumor growth and angiogenesis. Recent studies of Flt1 in several tumor cells suggest that VEGF/Flt1 signaling has autocrine survival activity [15] [16] [17] [18] . Treatment with anti-VEGF and anti-Flt1 antibodies inhibits ERK1/2 activation and downregulates Bcl-2 expression in the highly malignant neuroblastoma cell line SK-N-BE(2) [19] . Furthermore, reduced endogenous VEGF or VEGFR1 expressions induce apoptosis in MDA-MB-231 and MCF-7 breast cancer cells [20] . Our studies showed that Vegfa, Flt1 and Bcl-2 were down-regulated by a depletion of ZFAT in MEFs and MOLT-4 cells. One possible mechanism of apoptosis through the depletion of ZFAT might be the reduction of BCL-2 via the VEGF/Flt1 signaling pathway.
In summary, our report demonstrated that ZFAT is a critical regulator for cell survival in MEFs, and that the apoptosis induced by a depletion of ZFAT may be involved in BCL-2-mediated pathways. Further studies are necessary to elucidate the functional roles of the ZFAT-regulated genes identified in this study, and to identify the signaling pathways responsible for the induction of apoptosis through the depletion of ZFAT. Evidence is accumulating that ZFAT is an important factor in contributing to cellular differentiation, development and a variety of immunological diseases. Elucidation of the precise molecular mechanisms for ZFAT will provide important information not only for cellular programs but also for understanding the pathogenic mechanisms of diseases, and might provide specific targets for therapeutic intervention.
